Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tumor-Absorbed Dose for Non-Hodgkin Lymphoma Patients Treated with the Anti-CD37 Antibody Radionuclide Conjugate 177Lu-Lilotomab Satetraxetan

Published:2016-08-04 Issue:1 Volume:58 Page:48-54
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Blakkisrud Johan,Løndalen Ayca,Martinsen Anne C.T.,Dahle Jostein,Holtedahl Jon E.,Bach-Gansmo Tore,Holte Harald,Kolstad Arne,Stokke Caroline

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference27 articles.

1. Cancer statistics, 2015

2. Treatment challenges in the management of relapsed or refractory non-Hodgkin’s lymphoma: novel and emerging therapies;Chao;Cancer Manag Res.,2013

3. Comparison of 90Y-Ibritumomab Tiuxetan and 131I-Tositumomab in Clinical Practice

4. Targeted cancer therapy with a novel anti-CD37 beta-particle emitting radioimmunoconjugate for treatment of non-Hodgkin lymphoma;Repetto-Llamazares;PLoS One.,2015

5. Characterization of two murine monoclonal antibodies reactive with human B cells: their use in a high-yield, high-purity method for isolation of B cells and utilization of such cells in an assay for B-cell stimulating factor;Smeland;Scand J Immunol.,1985

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent preclinical and clinical advances in radioimmunotherapy for non-Hodgkin’s lymphoma;Exploration of Targeted Anti-tumor Therapy;2024-02-28

2. Therapeutic Monoclonal Antibodies for Non-Hodgkin Lymphoma: A Literature Review;Current Cancer Therapy Reviews;2024-01

3. Clinical Advances and Perspectives in Targeted Radionuclide Therapy;Pharmaceutics;2023-06-14

4. Radioimmunotherapy of Non-Hodgkin B-cell Lymphoma: An update;Seminars in Nuclear Medicine;2023-05

5. Neutronic simulation of medical radioisotope 99Mo and 177Lu production in IPR 14 MeV neutron generator facility;Applied Radiation and Isotopes;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3